Breaking News - Candlesense

BlackSky to Participate at Three Upcoming Investor Conferences

HERNDON, Va.--(BUSINESS WIRE)---- $BKSY--BlackSky Technology Inc. (NYSE: BKSY) will participate in the following upcoming investor events in September. Jefferies Industrials Conference Date: Wednes...

Symbol: BKSY

Investor events

21 days ago

Read more businesswire

CIBC Innovation Banking Provides Senior Credit Facilities to Vector

SAN FRANCISCO--(BUSINESS WIRE)--CIBC Innovation Banking announced today that it has provided growth financing to support Vector, a leading provider of workflow automation in the logistics industry....

Symbol: CM

Financing

21 days ago

Read more businesswire

EDB Postgres® AI Reduces Data Center Emissions by up to 87% and Energy Consumption by up to 81% for Large Enterprise Customers

WILMINGTON, Del.--(BUSINESS WIRE)--EnterpriseDB (“EDB”), the leading sovereign AI and data company, today published new independent research validating dramatic cost savings, energy efficiency, and...

Symbol: EDB

Energy

21 days ago

Read more businesswire

Genius Sports Announces Upcoming Conference Schedule

LONDON & NEW YORK--(BUSINESS WIRE)--Genius Sports Limited (NYSE:GENI) (“Genius Sports”), the official data, technology and broadcast partner that powers the global ecosystem connecting sports, bett...

Symbol: GENI

Conferences

21 days ago

Read more businesswire

PureTech Showcases Differentiated Development Strategy, Including New Patient Preference Insights, and Spotlights Phase 2b Data Positioning Deupirfenidone as a Potential New Standard of Care in IPF

BOSTON--(BUSINESS WIRE)--PureTech Demonstrates Strategic and Scientific Leadership in Idiopathic Pulmonary Fibrosis at 2025 IPF Summit

Symbol: PTIX

Clinical trials

21 days ago

Read more businesswire

Sarepta Therapeutics Announces Refinancing of Approximately $700 Million of 1.25% Convertible Senior Notes due 2027

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately...

How might this refinancing activity influence the stock's price momentum and trading volume in the short term? What are the specific terms of the exchange agreements, including conversion ratios and maturity dates, and how might they impact future dilution? How will the refinancing of the 1.25% convertible senior notes affect Sarepta Therapeutics' capital structure and credit profile?

Symbol: SRPT

Financing

21 days ago

Read more businesswire

Satellos to Participate in Four September Institutional and Retail Investor Conferences

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degen...

Symbol: MSCL

Investor events

21 days ago

Read more businesswire

LSI Industries Reports Fiscal 2025 Fourth Quarter and Full-Year Results and Declares Quarterly Cash Dividend

CINCINNATI--(BUSINESS WIRE)--LSI Industries Inc. (Nasdaq: LYTS, “LSI” or the “Company”) a leading U.S. based manufacturer of commercial lighting and display solutions, today reported financial resu...

How does LSI’s adjusted EBITDA margin compare to its key competitors, and what does this suggest about its operational efficiency moving forward? How will the declared quarterly cash dividend influence investor sentiment and the stock’s short‑term price action? What does the 20% YoY increase in net sales indicate about LSI Industries' growth trajectory and market demand?

Symbol: LYTS

Earnings

21 days ago

Read more businesswire

Enanta Pharmaceuticals to Participate in September Investor Conferences

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunologic...

Symbol: ENTA

Investor events

21 days ago

Read more businesswire

Sobi has completed issues of class C shares

STOCKHOLM, Aug. 21, 2025 /PRNewswire/ -- The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 8 May 2025 resolved on directed issues of redeemable and convertible class C sha...

How does this capital raise compare to recent financing activities of peer biotech companies, and what could be the market reaction to the repurchase authorization? What are the terms and pricing of the class C shares, and how might they influence the company's capital structure and cost of capital? How will the directed issuance of redeemable and convertible class C shares affect Sobi's share dilution and earnings per share?

Symbol: SOBI

Equity

21 days ago